Macitentan
Brand name: Opsumit
Rank #47 of 500 drugs by total cost
$394.6M
Total Cost
30,889
Total Claims
$394.6M
Total Cost
609
Prescribers
$13K
Cost per Claim
2,009
Beneficiaries
31,128
30-Day Fills
$648K
Avg Cost/Provider
51
Avg Claims/Provider
About Macitentan
Macitentan (sold as Opsumit) was prescribed 30,889 times by 609 Medicare Part D providers in 2023, costing the program $394.6M. At $13K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 44 | Levothyroxine Sodium (Levothyroxine Sodium) | $435.3M | 20,209,418 |
| 45 | Deutetrabenazine (Austedo) | $404.1M | 60,532 |
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
| 49 | Aripiprazole (Aripiprazole) | $373.1M | 1,494,971 |
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology